Mechanisms Underlying Impaired Diabetic Wound Healing (WoundVAC)

June 3, 2026 updated by: Sashwati Roy, University of Pittsburgh

Mechanisms Underlying Impaired Wound Healing

The overall aim of this research is to utilize wound derived inflammatory cells from diabetic versus non diabetic human chronic wounds to understand mechanisms that are responsible for disregulated inflammation in individuals with diabetes. Biology of normal (peripheral blood derived cells) versus wound derived cells will also be studied.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Specific aims:

  1. To study biology of wound derived inflammatory cells and fluid from diabetic versus non diabetic wounds.
  2. To characterize mechanisms that are responsible for dysregulated wound inflammatory cell function in individuals with diabetes.
  3. To characterize differences in the biology of normal peripheral blood derived cells versus wound derived cells.

The long-term goal of this study is to determine the molecular mechanisms underlying impaired wound healing in diabetics.

Study Type

Observational

Enrollment (Estimated)

250

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Piya Das Ghatak, PhD, MS
  • Phone Number: 412-648-8297
  • Email: pid12@pitt.edu

Study Contact Backup

  • Name: Urmila Gnyawali
  • Phone Number: 4126240422
  • Email: USG2@pitt.edu

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15219
      • Pittsburgh, Pennsylvania, United States, 15219
        • Recruiting
        • UPMC Presbyterian
        • Contact:
        • Contact:
          • Piya Das Ghatak, PhD
          • Phone Number: 412-648-8297
          • Email: pid12@pitt.edu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients are being recruited at the UPMC Montefiore. The study started at the Ohio State University, and then moved to Indiana University before moving to University of Pittsburgh in 2023.

Description

Inclusion Criteria:

  • Ages 21-80
  • Chronic Wound (present >4 weeks)
  • Diabetic & Non-diabetic
  • Adult surgical wounds

Exclusion Criteria:

  • Inability to consent
  • Pregnant women
  • Therapeutically immunocompromised
  • Individuals defined in 45 CFR 46 Subparts B,C, and D, nor from any other population considered vulnerable 2.9

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Chronic wound study
Patients with diabetes or no diabetes
Blood will be drawn from subjects once and VAC sponge will be collected (which is normally discarded material per standard of care).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wound healing
Time Frame: Week 16
Wound healing status
Week 16

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infection status
Time Frame: week 0
CFU analysis of the wound fluid
week 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sashwati Roy, Ph.D., University of Pittsburgh

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2008

Primary Completion (Estimated)

December 31, 2029

Study Completion (Estimated)

December 31, 2030

Study Registration Dates

First Submitted

October 21, 2008

First Submitted That Met QC Criteria

October 21, 2008

First Posted (Estimated)

October 22, 2008

Study Record Updates

Last Update Posted (Actual)

June 5, 2026

Last Update Submitted That Met QC Criteria

June 3, 2026

Last Verified

June 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe